Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
02/17/2010 | EP2152854A2 Methods for the direct conversion of carbon dioxide into a hydrocarbon using a metabolically engineered photosynthetic microorganism |
02/17/2010 | EP2152849A2 Production of oil in microorganisms |
02/17/2010 | EP2152755A1 Prevention and treatment of complement-associated eye conditions |
02/17/2010 | EP2152740A1 Products for altering il-33 activity and methods therefor |
02/17/2010 | EP2152233A1 High concentration factor vii polypeptide formulations comprising an aromatic preservative and an antioxidant |
02/17/2010 | EP2152099A1 Good tasting food product containing an agent for reducing carbohydrate uptake; and compositions containing such an agent |
02/17/2010 | EP1784085B1 Ferulate esterase producing strains and methods of using same |
02/17/2010 | EP1674578B1 Process for producing scyllo-inositol |
02/17/2010 | EP1644504B1 Factor vii or viia gla domain variants |
02/17/2010 | EP1627049B1 Novel trichoderma genes |
02/17/2010 | EP1565053B1 Compositions and methods for altering tocotrienol content |
02/17/2010 | EP1549318B1 Crystal structure of aurora-2 protein and binding pockets thereof |
02/17/2010 | EP1117814B1 Isoforms of starch branching enzyme ii (sbe-iia and sbe-iib) from wheat |
02/17/2010 | EP1073722B1 Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells |
02/17/2010 | EP1071700B1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
02/17/2010 | CN201403882Y Multifunction heat-transmission healthcare mattress |
02/17/2010 | CN101652474A Production of a lipid acyltransferase from transformed bacillus licheniformis cells |
02/17/2010 | CN101652473A Novel lysyl oxidases |
02/17/2010 | CN101649312A Human plasminogen K5 modified by RGD and preparation method and application thereof |
02/17/2010 | CN101649311A Preparation method of human lysozyme-antibacterial peptide Catesbeianin-1 fusion protein and application of same on preventing and curing cow mastitis |
02/17/2010 | CN101649310A Beta-glucosidase preparing method |
02/17/2010 | CN101649309A Method for producing cellulase through solid-state fermentation of raw materials |
02/17/2010 | CN101649308A Protein exhibiting activity of pyrethrin biosynthetic enzyme, gene encoding the protein, and vector bearing the gene |
02/17/2010 | CN101649307A Method and compositions for improved polynucleotide synthesis |
02/17/2010 | CN101649306A Enzyme capable of degrading pesticide carbendazim and encoding gene and application thereof |
02/17/2010 | CN100590198C Method and compositions for improved polynucleotide synthesis |
02/17/2010 | CN100590195C Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin B12 biosynthesis |
02/16/2010 | USRE41139 Polyunsaturated fatty acids in plants |
02/16/2010 | US7664625 Molecular modeling for metalloproteins |
02/16/2010 | US7662946 Sequences encoding ADAMTS13 genes and proteins |
02/16/2010 | US7662944 Nucleotide sequences coding prolyl dipeptidyl peptidase for use as tool in identifying modulators for prevention and treatment of activity neoplasia, type II diabetes, cirrhosis, autoimmunity, graft rejection and HIV infection |
02/16/2010 | US7662923 Modified vitamin K-dependent polypeptides |
02/16/2010 | US7662860 Cinanserin analogs were synthesized and tested at molecular and viral levels and were found to be able to inhibit the SARS-CoV virus 3CL Protease and SARS-CoV viruses, and may be used for treating and/or preventing SARS-CoV virus infection |
02/16/2010 | US7662770 Low molecular weight protein tyrosine phosphatase (LMW-PTP) as a diagnostic and therapeutic target |
02/16/2010 | US7662769 Acetylglucosaminyl transferases; neovascularization inhibitor screening; antibodies; kits |
02/16/2010 | US7662628 Method for producing a protein by culturing in culture medium a host cell transfected with a vector comprising a nucleic acid having the given nucleotide sequence; treatment of myocardial necrosis or ischemia reperfusion injuries; gene therapy; inhibits cell death associated with hypoxia, apoptosis |
02/16/2010 | US7662607 Chalaropsis lysozyme protein and its method of use in anti-bacterial applications |
02/16/2010 | US7662606 β-agarase isolated from Thalassomonas agarivorans, preparation process and uses thereof |
02/16/2010 | US7662605 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
02/16/2010 | US7662604 Chondroitinase ABC I and methods of production |
02/16/2010 | US7662603 serine hydroxymethyltransferase as novel target for herbicides |
02/16/2010 | US7662602 polypeptide which is encoded by a polynucleotide comprising a nuclotide sequence which hybridizes under at least high stringency conditions with the mature specific polypeptide coding sequence or its full-length complementary strand; detergent |
02/16/2010 | US7662601 thymine-DNA glycosylase (TDG) which releases thymine bases from single stranded (ss) DNA and double stranded (ds) DNA, said TDG obtainable by modification of a uracil-DNA glycosylase (UDG), wherein said modification consists of replacing tyrosine at amino acid position 147 with a different amino acids |
02/16/2010 | US7662600 Modified flavin adenine dinucleotide dependent glucose dehydrogenase |
02/16/2010 | US7662599 Polyketide synthetase activity; vectors; host cells |
02/16/2010 | US7662597 PUFA polyketide synthase systems and uses thereof |
02/16/2010 | US7662596 Aldolase, and method for producing optically active IHOG and monatin |
02/16/2010 | US7662594 adding to the RNA, a mixture of reverse transcriptase, a helicase and a single strand binding protein unless the helicase is a thermostable in which case binding protein is not required, a plurality of oligonucleotide primers and polymerase, reverse transcribing the RNA to form a cDNA and amplifying |
02/16/2010 | US7662584 Inducing an elevated unfolded protein response by using an isolated heterologous nucleic acid endocing a HAC1 protein, a PTC2 protein or an 1re1 protein; secreted therapeutic or an industrial enzyme |
02/16/2010 | US7662583 Nutrient medium free of exogenous supply of UDP-glucose; quercetin glycosylation |
02/16/2010 | US7662582 Method of identifying cancer biomarkers and cancer progression |
02/16/2010 | US7662581 kinesin-like motor proteins (Eg5) contacted with pharmacophore such as N-(3-aminopropyl)-N-[(3-benzyl-4-oxo-4H-pyrido[1,2a]pyrimidin-2-yl)(cyclopropyl)methyl]-4-chlorobenzamide; drug screening |
02/16/2010 | US7662565 Approaches to identify less harmful tobacco and tobacco products |
02/16/2010 | US7662556 Isolating and cloning full-lengh gene sequences using capped messenger RNA |
02/16/2010 | US7662415 Microbially expresses xylanases and their use as feed additives and other uses |
02/16/2010 | US7662374 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
02/16/2010 | US7662372 Insect inhibitory lipid acyl hydrolases |
02/16/2010 | CA2696934A1 Transgenic mice |
02/16/2010 | CA2614785C Regulation of antigen presentation |
02/16/2010 | CA2284688C Corn pullulanase |
02/11/2010 | WO2010016621A1 Rna polymerase mutant with improved functions |
02/11/2010 | WO2010015899A2 Novel method to generate meganucleases with altered characteristics |
02/11/2010 | WO2010015722A1 Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof |
02/11/2010 | WO2010015264A1 L-asparaginase from helicobacter pylori |
02/11/2010 | WO2010015090A1 Functionalized pyrrolidines and use thereof as iap inhibitors |
02/11/2010 | WO2009130602A3 Factor ix conjugates with extended half-lives |
02/11/2010 | US20100037354 Transgenic plants containing altered levels of steroid compounds |
02/11/2010 | US20100037345 Polypeptide having Methionine Synthesis Function, Polynucleotide Encoding the Polypeptide, and Those Use |
02/11/2010 | US20100035945 Small molecule inhibitors of bacterial dam dna methyltransferases |
02/11/2010 | US20100035885 Compositions for manipulating the lifespan and stress response of cells and organisms |
02/11/2010 | US20100035787 Compositions and Uses for an Alpha-Amylase Polypeptide of Bacillus Species 195 |
02/11/2010 | US20100035767 Polymerase |
02/11/2010 | US20100035339 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor |
02/11/2010 | US20100035329 recombinant yeast comprising one or more heterologous nucleic acid molecules encoding an enzyme that converts converts hydroxymethylglutaryl-CoA to mevalonic acid, mevalonic acid to phosphomevalonic acid, phosphomevalonic acid to phosphomevalonate, phosphomevalonate to isopentenyl pyrophosphate |
02/11/2010 | US20100035326 Nucleic Acid Terminators Incorporating a Cationic Moiety and Methods for Their Use |
02/11/2010 | US20100035325 Microcapsules and methods of use for amplification and sequencing |
02/11/2010 | US20100035317 Novel alcohol dehydrogenase, gene for the alcohol dehydrogenase, vector, transformant, and method for production of optically active alcohol by using them |
02/11/2010 | US20100035314 Method for the enzymatic production of 2-hydroxy-2-methyl carboxylic acids |
02/11/2010 | US20100035313 Microorganism capable of producing polyhydroxyalkanoate, polyhydroxyalkanoate synthase, and gene encoding the same |
02/11/2010 | US20100035311 Method and composition for enzyme storage |
02/11/2010 | US20100035306 Fermentation of pentose sugars |
02/11/2010 | US20100035299 Methods for the purification of polypeptide conjugates |
02/11/2010 | US20100035291 Method for degrading peptides, method for analyzing peptides, device for degrading peptides and device for analyzing peptides |
02/11/2010 | US20100035271 Modification of Collagenous Materials and Medical Treatment, Diagnosis and Monitoring of Fibrotic Conditions |
02/11/2010 | US20100035260 Compositions, devices, systems, for using a Nanopore |
02/11/2010 | US20100035256 Enduracidin biosynthetic gene cluster from streptomyces fungicidicus |
02/11/2010 | US20100035254 Polymerase-nucleic acid complex comprising anchor which irreversibly associates target nucleotide with multimeric complex for use as tool in enhancing polymerase processivity in DNA sequencing; detecting incorporation of a labeled nucleotide triphosphate onto the growing end of a primer nucleic acid |
02/11/2010 | US20100035238 Anti-freeze protein enhanced nucleic acid amplification |
02/11/2010 | US20100034842 Compositions Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease |
02/11/2010 | US20100034804 Mutants of streptokinase and their covalently modified forms |
02/11/2010 | US20100034802 Treatment of pain |
02/11/2010 | US20100034800 Compositions for detecting cell death and methods of use thereof |
02/11/2010 | US20100034799 Anti-cocaine compositions and treatment |
02/11/2010 | US20100034797 Lipase Variants for Pharmaceutical Use |
02/11/2010 | US20100034780 Tumor antigen peptide derived from amacr |
02/11/2010 | CA2733362A1 Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof |
02/10/2010 | EP2151500A1 Branched -glucan, -glucosyltransferase producing the same, method for producing the same and use thereof |
02/10/2010 | EP2151494A2 Maltogenic alpha-amylase variants |
02/10/2010 | EP2151454A2 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
02/10/2010 | EP2151448A1 Glycosylate derivatives of mithramycin, method of preparation and uses thereof |